Shield Therapeutics (GB:STX) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Shield Therapeutics has launched a RetailBook Offer, allowing existing UK shareholders to purchase new ordinary shares at a premium price of 3.0p per share, raising up to £1 million. This offer is available through partners like AJ Bell and Hargreaves Lansdown and can be accessed using ISAs or SIPPs. The offer closes on December 20, 2024, with no commission charged by RetailBook.
For further insights into GB:STX stock, check out TipRanks’ Stock Analysis page.
